Monaco Asset Management SAM
- SEC CIK
- 0001803593
- Latest filing
- Aug 7, 2026
FATE holding history
Fate Therapeutics Inc in every 13F filed by Monaco Asset Management SAM, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FATE overviewAll 13F holders of FATEFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −810,000−100.0% | Sold out | Holders |
| Q1 2026 | 810,000 | $972.0K | 0.3% | −20,000−2.4% | Reduced | Holders |
| Q4 2025 | 830,000 | $815.6K | 0.2% | +60,000+7.8% | Added | Holders |
| Q3 2025 | 770,000 | $970.2K | 0.4% | +95,000+14.1% | Added | Holders |
| Q2 2025 | 675,000 | $756.0K | 0.3% | −474,708−41.3% | Reduced | Holders |
| Q1 2025 | 1,149,708 | $908.4K | 0.5% | +822,037+250.9% | Added | Holders |
| Q4 2024 | 327,671 | $540.7K | 0.2% | +190,000+138.0% | Added | Holders |
| Q3 2024 | 137,671 | $481.8K | 0.2% | −149,229−52.0% | Reduced | Holders |
| Q2 2024 | 286,900 | $941.0K | 0.5% | −29,905−9.4% | Reduced | Holders |
| Q1 2024 | 316,805 | $2.33M | 1.0% | −1,866,423−85.5% | Reduced | Holders |
| Q4 2023 | 2,183,228 | $8.17M | 3.1% | +335,284+18.1% | Added | Holders |
| Q3 2023 | 1,847,944 | $3.92M | 2.0% | +842,718+83.8% | Added | Holders |
| Q2 2023 | 1,005,226 | $4.78M | 2.6% | +34,933+3.6% | Added | Holders |
| Q1 2023 | 970,293 | $5.53M | 2.5% | +720,293+288.1% | Added | Holders |
| Q4 2022 | 250,000 | $2.52M | 0.9% | +250,000 | New | Holders |